Results 271 to 280 of about 143,942 (291)
Some of the next articles are maybe not open access.

PNPLA3 and obesity: a synergistic relationship in NAFLD

Nature Reviews Gastroenterology & Hepatology, 2017
NAFLD, the hepatic manifestation of the metabolic syndrome, is a multifactorial condition — environmental factors influence an inherited genetic risk. Stender et al. now describe the additive effect of obesity and NAFLD-associated genetic polymorphisms on steatosis, elevated serum alanine aminotransferase levels and cirrhosis, remarkably illustrating ...
Mann JP, Anstee QM
openaire   +3 more sources

NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance

Journal of Clinical and Experimental Hepatology
Non-alcoholic fatty liver disease (NAFLD) is rapidly emerging as a leading etiology of chronic liver disease (CLD) in Asia. The increasing incidence of NAFLD is projected to drive a surge in NAFLD-related hepatocellular carcinoma (HCC). A notable characteristic of NAFLD-HCC is its capacity for development in individuals without cirrhosis in more than a
Jia H. Koh   +5 more
openaire   +2 more sources

Nicht-alkoholische Fettlebererkrankung (NAFLD)

DMW - Deutsche Medizinische Wochenschrift, 2015
Leicht, Hans Benno   +2 more
openaire   +1 more source

Breastfeeding to Prevent NAFLD

Hepatology, 2021
George Boon‐Bee Goh   +2 more
openaire   +2 more sources

NAFLD

2009
Stephan J. Froehlich   +87 more
openaire   +1 more source

Lean NAFLD

Journal of Pediatric Gastroenterology and Nutrition, 2018
Praveen Kumar Conjeevaram Selvakumar   +2 more
openaire   +1 more source

NAFLD/NASH and Diabetes

Diabetes Technology & Therapeutics, 2020
Kavita, Garg   +3 more
openaire   +2 more sources

NAFLD incidence is increasing

Nature Reviews Gastroenterology & Hepatology, 2023
openaire   +2 more sources

Nanoparticles in NAFLD therapeutics

Nature Reviews Gastroenterology & Hepatology, 2023
openaire   +2 more sources

Home - About - Disclaimer - Privacy